genetic testing
Nightingale Health to Acquire Genetic Testing Firm Negen
Through the acquisition, Nightingale intends to combine its metabolite-based blood test with genomic data to improve early disease risk detection.
23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test
The firm is now authorized to sell a genetic health report on the HOXB13 marker that indicates risk for hereditary prostate cancer, its third DTC cancer risk report with 510(k) clearance.
Top 10 Articles on GenomeWeb in 2021
The most-read stories in 2021 represents readers' vast interests in the variety of topics covered by GenomeWeb from COVID-19 tests to IPOs and legal battles.
Baylor Genetics, SRL Ink Clinical Sequencing Tech Transfer Agreement
Under the agreement, Baylor Genetics will transfer its clinical-grade whole-genome and whole-exome sequencing technology to SRL beginning in 2022.
HHS OIG Finds Sharp Rise in Medicare Payments for Genetic Tests
Medicare payments for genetic tests and the number of such tests rose sharply, as did the number of labs receiving more than $1 million in reimbursements for such tests.